IRPSX
Price
$10.39
Change
-$0.06 (-0.57%)
Updated
Sep 5 closing price
Net Assets
285.43M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

IRPSX vs VIVIX

Header iconIRPSX vs VIVIX Comparison
Open Charts IRPSX vs VIVIXBanner chart's image
VY® T. Rowe Price Equity Income S
Price$10.39
Change-$0.06 (-0.57%)
VolumeN/A
Net Assets285.43M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
IRPSX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRPSX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRPSX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. IRPSX (285M). VIVIX pays higher dividends than IRPSX: VIVIX (2.11) vs IRPSX (1.56). IRPSX was incepted earlier than VIVIX: IRPSX (37 years) vs VIVIX (27 years). IRPSX (0.89) is less costly to investors than VIVIX (0.04). IRPSX is a more actively managed with annual turnover of: 21.00 vs. VIVIX (9.00). IRPSX has a lower initial minimum investment than VIVIX: IRPSX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. IRPSX (-3.34). VIVIX return over 5 years is better than : 70.16 vs. IRPSX (31.95).
IRPSXVIVIXIRPSX / VIVIX
Total Expense Ratio0.860.042,150%
Annual Report Gross Expense Ratio0.890.042,225%
Fund Existence37 years27 years-
Gain YTD-2.7937.866-36%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M203B0%
Annual Yield % from dividends1.562.1174%
Returns for 1 year-3.347.74-43%
Returns for 3 years9.6036.6126%
Returns for 5 years31.9570.1646%
Returns for 10 years-1.79131.61-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia